BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38596550)

  • 1. Tachycardia Therapy Outcomes of Ischemic Versus Nonischemic Cardiomyopathy on Cardiac Resynchronization Therapy: A Propensity Score-matched Analysis.
    Malik J; Awais M; Shabbir M; Rauf A; Zaffar S; Hayat A; Mehmoodi A
    J Community Hosp Intern Med Perspect; 2023; 13(6):83-89. PubMed ID: 38596550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement.
    Beiert T; Straesser S; Malotki R; Stöckigt F; Schrickel JW; Andrié RP
    Arch Med Sci; 2019 Jul; 15(4):845-856. PubMed ID: 31360179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.
    Barra S; Boveda S; Providência R; Sadoul N; Duehmke R; Reitan C; Borgquist R; Narayanan K; Hidden-Lucet F; Klug D; Defaye P; Gras D; Anselme F; Leclercq C; Hermida JS; Deharo JC; Looi KL; Chow AW; Virdee M; Fynn S; Le Heuzey JY; Marijon E; Agarwal S;
    J Am Coll Cardiol; 2017 Apr; 69(13):1669-1678. PubMed ID: 28359511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
    McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
    Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT.
    Mittal S; Aktas MK; Moss AJ; McNitt S; Kutyifa V; Steinberg JS; Zareba W
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1082-7. PubMed ID: 24862906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.
    Leyva F; Taylor RJ; Foley PW; Umar F; Mulligan LJ; Patel K; Stegemann B; Haddad T; Smith RE; Prasad SK
    J Am Coll Cardiol; 2012 Oct; 60(17):1659-67. PubMed ID: 23021326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Titin-Truncating Genetic Variants With Life-threatening Cardiac Arrhythmias in Patients With Dilated Cardiomyopathy and Implanted Defibrillators.
    Corden B; Jarman J; Whiffin N; Tayal U; Buchan R; Sehmi J; Harper A; Midwinter W; Lascelles K; Markides V; Mason M; Baksi J; Pantazis A; Pennell DJ; Barton PJ; Prasad SK; Wong T; Cook SA; Ware JS
    JAMA Netw Open; 2019 Jun; 2(6):e196520. PubMed ID: 31251381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.
    Doran B; Mei C; Varosy PD; Kao DP; Saxon LA; Feldman AM; DeMets D; Bristow MR
    JACC Heart Fail; 2021 Jun; 9(6):439-449. PubMed ID: 33992570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Outcomes after Catheter Ablation of Ventricular Tachycardia in Dilated vs. Ischemic Cardiomyopathy.
    Chakarov I; Mueller J; Ene E; Berkovitz A; Sonne K; Nentwich K; Schupp T; Behnes M; Deneke T
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
    Husaini M; Biton Y; Stair B; Moss AJ; Biering-Sørensen T; Solomon S; McNitt S; Polonsky B; Zareba W; Barsheshet A; Kutyifa V
    Cardiol J; 2016; 23(4):437-45. PubMed ID: 27320956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
    Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study.
    Fang CY; Chen HC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC; Lee WC
    PeerJ; 2018; 6():e5312. PubMed ID: 30038875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study.
    Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK
    Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septal Midwall Late Gadolinium Enhancement in Ischemic Cardiomyopathy and Nonischemic Dilated Cardiomyopathy-Characteristics and Prognosis.
    Becker MAJ; van der Lingen ACJ; Cornel JH; van de Ven PM; van Rossum AC; Allaart CP; Germans T
    Am J Cardiol; 2023 Aug; 201():294-301. PubMed ID: 37393732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary ICD Therapy.
    Narins CR; Aktas MK; Chen AY; McNitt S; Ling FS; Younis A; Zareba W; Daubert JP; Huang DT; Rosero S; Kutyifa V; Goldenberg I
    JACC Clin Electrophysiol; 2022 Jan; 8(1):1-11. PubMed ID: 34454875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy.
    Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA
    Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive values of left ventricular mechanical dyssynchrony for CRT response in heart failure patients with different pathophysiology.
    He Z; Li D; Cui C; Qin HY; Zhao Z; Hou X; Zou J; Chen ML; Wang C; Zhou W
    J Nucl Cardiol; 2022 Oct; 29(5):2637-2648. PubMed ID: 34535872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
    Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F; Herrmann T; Kuschyk J; Lang S; Doesch C; Papavassiliu T; Streitner I; Veltmann C; Haghi D; Borggrefe M
    PLoS One; 2013; 8(5):e63911. PubMed ID: 23675514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.